SEC Filing Summary: Hemispherx Biopharma, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report (Form 8-K) was filed on September 12, 2003, by Hemispherx Biopharma, Inc. regarding events occurring at the Company's Annual Meeting of Stockholders held on September 10, 2003. The filing details the outcomes of shareholder votes on director elections, auditor ratification, and corporate charter amendments.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes and Voting Results
Stockholders approved three major proposals with the following results:
- Director Elections: Five directors were elected. Total shares voted were 27,003,653 out of 35,821,275 eligible.
- William A. Carter, M.D.: 22,344,867 For / 4,658,786 Withheld
- Richard C. Piani, Esq.: 24,899,018 For / 2,104,635 Withheld
- Ransom W. Etheridge, Esq.: 22,942,478 For / 4,061,175 Withheld
- William M. Mitchell, Ph.D., M.D.: 23,903,718 For / 3,099,935 Withheld
- Iraj-Eqhbal Kiani, Ph.D.: 24,269,933 For / 2,733,720 Withheld
- Auditor Ratification: BDO Seidman, LLP was ratified as independent auditors for the year ending December 31, 2003.
- For: 25,033,555
- Against: 1,960,625
- Abstain: 9,473
- Charter Amendment: The Certificate of Incorporation was amended to increase authorized common stock from 50,000,000 to 100,000,000 shares.
- For: 24,695,036
- Against: 2,298,867
- Abstain: 9,750
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, or contingencies. The document is limited to reporting the results of the shareholder meeting.
Key Facts for Investor Verification
- Verify the effective date of the increase in authorized shares from 50 million to 100 million.
- Confirm the tenure and specific roles of the newly elected directors.
- Review the full audit report from BDO Seidman, LLP for the fiscal year ending December 31, 2003, to assess financial health.
- Check subsequent filings for any dilution resulting from the increased authorized share count.